Pediatric cellular therapies and transplants are among the most promising advancements in modern medicine, offering hope to children battling life-threatening diseases like leukemia, thalassemia, and immune disorders. However, ensuring equitable access, high-quality treatment, and better patient outcomes requires a robust ecosystem that fosters innovation, collaboration, and capacity building. The Society for Pediatric Cellular Therapy and Transplant (SPCTT) stands at the forefront of this mission, aiming to transform the landscape of pediatric care in India, and the world.

SPCTT’s primary goal is to bridge gaps between research, clinical practice, and public health. By facilitating collaboration among clinicians, researchers, and policymakers, SPCTT promotes the development of cutting-edge therapies tailored for pediatric patients. Through workshops, conferences, and training programs, the organization empowers healthcare providers with knowledge and skills to deliver state-of-the-art treatments.

Besides, SPCTT emphasises research and innovation, supporting studies on novel treatments like CAR-T cells and gene therapies. Through public-private partnerships, international collaborations, and leveraging global expertise, it ensures Indian children benefit from the latest advancements.

With a vision of creating a comprehensive ecosystem for pediatric care, SPCTT is not just improving outcomes—it is shaping a future where every child has access to advanced therapies and a chance at a healthier life.

NOTE: The SPCTT is established in April 2022 under the Societies Registration Act, 1860